{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:07:07Z","timestamp":1792454827322,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejps.2023.106537","type":"journal-article","created":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T09:46:32Z","timestamp":1690105592000},"page":"106537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Protein corona formation on lipidic nanocapsules: Influence of the interfacial PEG repartition"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-3796","authenticated-orcid":false,"given":"Vincent","family":"Lebreton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Legeay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia","family":"Vasylaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred\u00e9ric","family":"Lagarce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejps.2023.106537_bib0049","first-page":"889","article-title":"Use of the post-insertion method for the formation of ligand-coupled liposomes","volume":"7","author":"Allen","year":"2002","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejps.2023.106537_bib0038","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s13346-020-00745-0","article-title":"Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers","volume":"10","author":"Berrecoso","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2023.106537_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2023.106537_bib0051","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1788","article-title":"Influence of surface chemistry and morphology of nanoparticles on protein corona formation","volume":"14","author":"Bilardo","year":"2022","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ejps.2023.106537_bib0008","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nano.2014.11.003","article-title":"Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines","volume":"11","author":"Caracciolo","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejps.2023.106537_bib0011","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1073\/pnas.0608582104","article-title":"Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles","volume":"104","author":"Cedervall","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2023.106537_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2017.02.008","article-title":"Stealth nanocarriers based sterosomes using PEG post-insertion process","author":"Cie\u015blak","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2023.106537_bib0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ijpharm.2017.04.048","article-title":"Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona","volume":"532","author":"Coty","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106537_bib0043","series-title":"Methods For Structural Analysis of Protein Pharmaceuticals","author":"Demeester","year":"2005"},{"key":"10.1016\/j.ejps.2023.106537_bib0022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2019.04.027","article-title":"Nanomedicines for improved targetability to inflamed synovium for treatment of rheumatoid arthritis: multi-functionalization as an emerging strategy to optimize therapeutic efficacy","volume":"303","author":"Fang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106537_bib0041","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","article-title":"Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates","volume":"27","author":"Filipe","year":"2010","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejps.2023.106537_bib0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11095-021-03034-8","article-title":"Characterization of biological material adsorption to the surface of nanoparticles without a prior separation step: a case study of glioblastoma-targeting peptide and lipid nanocapsules","volume":"38","author":"Gazaille","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106537_bib0047","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"Stealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEGchain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","author":"Gref","year":"2000","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejps.2023.106537_bib0034","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/nnm.14.124","article-title":"In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor","volume":"10","author":"Groo","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2023.106537_bib0042","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acs.molpharmaceut.9b01111","article-title":"How corona formation impacts nanomaterials as drug carriers","volume":"17","author":"Gupta","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2023.106537_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.ejps.2023.106537_bib0025","doi-asserted-by":"crossref","unstructured":"B. Heurtault, P. Saulnier, B. Pech, J.E. Proust, J.P. Benoit, A Novel Phase Inversion-Based Process For the Preparation of Lipid Nanocarriers, 2002.","DOI":"10.1023\/A:1016121319668"},{"key":"10.1016\/j.ejps.2023.106537_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/ma14237416","article-title":"Surface characterisation of human serum albumin layers on activated ti6al4v","volume":"14","author":"Hierro-Oliva","year":"2021","journal-title":"Materials"},{"key":"10.1016\/j.ejps.2023.106537_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2012.08.005","article-title":"Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models","author":"Hirsj\u00e4rvi","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejps.2023.106537_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2009.04.026","article-title":"Lipid nanocapsules: a new platform for nanomedicine","author":"Huynh","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106537_bib0021","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1039\/C9NR08186K","article-title":"In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow","volume":"12","author":"Kari","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejps.2023.106537_bib0015","doi-asserted-by":"crossref","first-page":"11773","DOI":"10.1021\/acsnano.7b08008","article-title":"A decade of the protein corona","volume":"11","author":"Ke","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2023.106537_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.05.042","article-title":"The hard protein corona of stealth liposomes is sparse","volume":"307","author":"Kristensen","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106537_bib0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jconrel.2022.09.057","article-title":"Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique","volume":"351","author":"Lebreton","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106537_bib0056","doi-asserted-by":"crossref","first-page":"8799","DOI":"10.1021\/acs.langmuir.9b01325","article-title":"Cross-linked poly(ethylene glycol) shells for nanoparticles: enhanced stealth effect and colloidal stability","volume":"35","author":"Li","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2023.106537_bib0012","doi-asserted-by":"crossref","first-page":"14265","DOI":"10.1073\/pnas.0805135105","article-title":"Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts","volume":"105","author":"Lundqvist","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2023.106537_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175871","article-title":"The nanoparticle protein corona formed in human blood or human blood fractions","volume":"12","author":"Lundqvist","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2023.106537_bib0005","doi-asserted-by":"crossref","unstructured":"I. Lynch, K.A. Dawson, Protein-nanoparticle interactions, 2008.","DOI":"10.1016\/S1748-0132(08)70014-8"},{"key":"10.1016\/j.ejps.2023.106537_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cis.2007.04.021","article-title":"The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century","volume":"134\u2013135","author":"Lynch","year":"2007","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2023.106537_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.01.002","article-title":"Nanocarrier vaccines for SARS-CoV-2","author":"Machhi","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106537_bib0050","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijpharm.2018.10.028","article-title":"Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes","volume":"552","author":"Mare","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106537_bib0024","unstructured":"A. Mcgoron, M. Fujita, F. Jadidi-Niaragh, N.M. La-Beck, L.M. Wood, X. Liu, Harnessing Liposome Interactions With the Immune System For the Next Breakthrough in Cancer Drug Delivery, (2019). 10.3389\/fphar.2019.00220."},{"key":"10.1016\/j.ejps.2023.106537_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2009.09.044","article-title":"Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting","author":"Morille","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2023.106537_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179211","article-title":"Surface active properties of lipid nanocapsules","author":"Mouzouvi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2023.106537_bib0003","article-title":"Nanomedicine and the COVID-19 vaccines","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejps.2023.106537_bib0052","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/jcis.2000.7264","article-title":"Dynamic electrophoretic mobility of a soft particle","volume":"233","author":"Ohshima","year":"2001","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2023.106537_bib0037","series-title":"Theory of Colloid and Interfacial Electric Phenomena","author":"Ohshima","year":"2006"},{"key":"10.1016\/j.ejps.2023.106537_bib0036","doi-asserted-by":"crossref","DOI":"10.1088\/1468-6996\/10\/6\/063001","article-title":"Theory of electrostatics and electrokinetics of soft particles","volume":"10","author":"Ohshima","year":"2009","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.ejps.2023.106537_bib0013","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbamem.2015.11.012","article-title":"The protein corona of circulating PEGylated liposomes","volume":"1858","author":"Palchetti","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejps.2023.106537_bib0009","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1166\/jnn.2018.15766","article-title":"Formation and characterization of protein corona around nanoparticles: a review","volume":"18","author":"Pareek","year":"2018","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ejps.2023.106537_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2022.02.025","article-title":"Perspective on drug delivery in 2050","author":"Park","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106537_bib0057","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2010.01.025","article-title":"To PEGylate or not to PEGylate, that is not the question","volume":"142","author":"Park","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106537_bib0014","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.2147\/IJN.S254808","article-title":"Protein\u2013nanoparticle interaction: corona formation and conformational changes in proteins on nanoparticles","volume":"15","author":"Park","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2023.106537_bib0053","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2019.05.006","article-title":"Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles","volume":"141","author":"Partikel","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2023.106537_bib0045","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1021\/acsnano.5b01326","article-title":"Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake","volume":"9","author":"Pelaz","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2023.106537_bib0026","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s11095-006-0022-2","article-title":"Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules","volume":"23","author":"Peltier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106537_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/chem.201000808","article-title":"Methods for the functionalisation of nanoparticles: new insights and perspectives","author":"Perrier","year":"2010","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.ejps.2023.106537_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00166","article-title":"Recent advances in understanding the protein corona of nanoparticles and in the formulation of \u201cStealthy\u201d nanomaterials","volume":"8","author":"Rampado","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejps.2023.106537_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2011.01.021","article-title":"Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration","author":"Roger","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2023.106537_bib0029","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejps.2013.06.013","article-title":"Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide","volume":"50","author":"Saliou","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106537_bib0059","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biomaterials.2015.04.049","article-title":"Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules","volume":"61","author":"S\u00e1nchez-Moreno","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2023.106537_bib0006","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.tips.2020.06.011","article-title":"Biomolecular corona affects controlled release of drug payloads from nanocarriers","volume":"41","author":"Sharifi","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2023.106537_bib0017","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1021\/nn201950e","article-title":"Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis","volume":"5","author":"Tenzer","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2023.106537_bib0001","doi-asserted-by":"crossref","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","author":"Tran","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejps.2023.106537_bib0018","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3762\/bjnano.6.88","article-title":"Protein corona - from molecular adsorption to physiological complexity","volume":"6","author":"Treuel","year":"2015","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.ejps.2023.106537_bib0010","doi-asserted-by":"crossref","unstructured":"D.A. Tyrrell, V.J. Richardson, B.E. Ryman, The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver, 1977.","DOI":"10.1016\/0304-4165(77)90204-5"},{"key":"10.1016\/j.ejps.2023.106537_bib0020","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/acsnano.6b04858","article-title":"Understanding the kinetics of protein-nanoparticle corona formation","volume":"10","author":"Vilanova","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2023.106537_bib0046","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.ejps.2023.106537_bib0058","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1021\/acsnano.8b04947","article-title":"Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation","volume":"12","author":"Zhou","year":"2018","journal-title":"ACS Nano."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:06:52Z","timestamp":1760530012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":59,"alternative-id":["S0928098723001677"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106537","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein corona formation on lipidic nanocapsules: Influence of the interfacial PEG repartition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106537"}}